Opportunities span cytotoxicity, phenotypic and morphological assays, flow cytometry, and pharma and biotech demand.

This article and associated images are based on a poster originally authored by Denise Sullivan, Zhong Yu, Benjamin Streeter, Stacie Chvatal and Daniel Millard and presented at ELRIG Drug Discovery ...

Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...

Advanced 3D spheroid models are being widely acknowledged as a vital tool for better evaluation of cancer immunotherapy agents in-vitro. This article describes the potential to kinetically visualize ...

Research and development of monoclonal antibody (mAb) therapeutics is a vast and expanding area of drug discovery, largely due to mAb potential for high specificity and affinity towards target ...